SCHEMBL17362285

SCHEMBL17362285

Cn1ccc2nc(-c3cccc(-c4ccccc4)c3F)cnc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5AP P20292 2/20 0.41
▸ FEN1 P39748 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ KDR P35968 2/20 0.38
▸ PDGFRB P09619 1/20 0.38
▸ FLT3 P36888 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.35
▸ GLA P06280 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35
▸ ALDH1A3 P47895 2/20 0.35
▸ HSD11B1 P28845 1/20 0.35
▸ MET P08581 2/20 0.35
▸ NR1H2 P55055 1/20 0.34
▸ NR1H3 Q13133 1/20 0.34
▸ ALDH1A2 O94788 1/20 0.34
▸ APP P05067 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17362387 0.84 ALOX5AP (0.39) ALOX5APFEN1SMN1; SMN2NPC1RAB9A
SCHEMBL17362187 0.79 APP (0.47) HSD11B1APP
SCHEMBL17362242 0.72 ALOX5AP (0.39) ALOX5APFEN1SMN1; SMN2NPC1RAB9A
SCHEMBL17362356 0.68 ALOX5AP (0.43) ALOX5APFEN1SMN1; SMN2NPC1RAB9A
SCHEMBL2483816 0.68 TGFBR1 (0.47) ALOX5APFEN1SMN1; SMN2NPC1RAB9A
SCHEMBL12791085 0.67 JAK2 (0.48) NPC1MAPTMET
SCHEMBL2135621 0.66 ALDH1A1 (0.48) ALOX5APFEN1ALDH1A1HDAC6PDCD1
SCHEMBL17362332 0.66 FEN1 (0.52) ALOX5APFEN1SMN1; SMN2NPC1RAB9A
SCHEMBL17362410 0.66 ALOX5AP (0.40) ALOX5APFEN1SMN1; SMN2NPC1RAB9A
SCHEMBL17362391 0.66 GRIN2B (0.35) ALOX5APFEN1MAPTAPPCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9745328-B2 Flap modulators JANSSEN PHARMACEUTICA NV (BE) 2017-08-29 — — US disclosed
US-20150376212-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-12-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150376212-A1 FLAP MODULATORS FEN1, PGF, TBXA2R ALOX5AP 95/4885FEN1 1/4885SMN1; SMN2 3245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback